Acelrx Pharmaceuticals Incの資産のリターン
Acelrx Pharmaceuticals Incの資産のリターン は何ですか。
Acelrx Pharmaceuticals Incの資産のリターン は-74.46%です。
資産のリターン の定義は何ですか。
資産のリターンは 、企業の資産が収益を生み出す際の収益性を示します。純利益を平均総資産で除して計算されます。
The return on assets (ROA) tells you what the company can do with what it has, i.e. how many dollars of earnings they derive from each dollar of assets they control. It's a useful number for comparing competing companies in the same industry. The number will vary widely across different industries. Return on assets gives an indication of the capital intensity of the company, which will depend on the industry; companies that require large initial investments will generally have lower return on assets. ROAs over 5% are generally considered good.
NASDAQのセクタHealth Careにおける資産のリターン の企業と比べるAcelrx Pharmaceuticals Inc
Acelrx Pharmaceuticals Incは何をしますか。
acelrx pharmaceuticals inc. is a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of moderate-to-severe acute pain. the company’s product candidates, dsuvia™ (known as arx-04 outside of the united states) and zalviso®, are designed to deliver sufentanil, a strong opioid analgesic, via a non-invasive, sublingual formulation in medical supervised settings. dsuvia is designed to deliver sublingual tablets containing 30 mcg sufentanil via a disposable, pre-filled, single-dose applicator. the phase 3 clinical program has completed and assessed the investigational product in the treatment of moderate-to-severe acute pain in patients who had undergone surgery or who presented to an emergency room with trauma or injury. in clinical studies, dsuvia demonstrated reductions in pain intensity as early as 15-to-30 minutes after the start of dosing and the most common adverse events included nausea, headache, dizziness, and v
Acelrx Pharmaceuticals Incと類似の資産のリターン
- Angkor Resourcesの資産のリターン は-74.64%です。
- Agenus Incの資産のリターン は-74.59%です。
- Verb Technologyの資産のリターン は-74.49%です。
- Sire Bioscienceの資産のリターン は-74.48%です。
- Odd Burgerの資産のリターン は-74.47%です。
- Globally Local Technologiesの資産のリターン は-74.47%です。
- Acelrx Pharmaceuticals Incの資産のリターン は-74.46%です。
- Odyssey Semiconductor Technologiesの資産のリターン は-74.43%です。
- CannaGrowの資産のリターン は-74.40%です。
- Ennox Ltdの資産のリターン は-74.39%です。
- Hoth Therapeuticsの資産のリターン は-74.38%です。
- Copper Lake Resourcesの資産のリターン は-74.31%です。
- Ef funders Ventures Incの資産のリターン は-74.31%です。